A passionate and results-oriented CMC leader with a career track record of success in providing strategic planning and technical guidance, and ensuring the timely delivery of high-quality pharmaceutical products to support all stages of drug product development lifecycle. Proactively identify and implement effective process improvements to accelerate development timeline. Led a cross-functional team to complete drug product development, process optimization, scale-up, validation and NDA submission successfully within 4 years from the candidate nomination for an oncology drug. Seeking a full-time position that offers professional challenges utilizing my strong technical expertise in CMC development, great interpersonal skills, excellent project management and problem-solving skills.
CORE COMPETENCIES AND QUALIFICATIONS
Highly-skilled and experienced in multiple aspects of small molecule CMC development including API polymorph & salt screening/characterization, preformulation, analytical method development/validation, formulation/process development and manufacture, stability evaluation
Over 20 years of experiences in developing variety of dosage forms (solution, suspensions, liposomes, solid oral dosage forms) to support IND enabling, non-clinical and all phases of clinical studies for different patient populations
Strong technical expertise in solid oral dosage form development, process scale-up, tech transfer and validation with sound understanding of major processing equipment and unit operations (e.g. Wet and Dry Granulation, Fluid Bed Drying, Compression, Spray Drying, etc. )
Extensive experiences in collaborating with external CROs/CMOs and depots for drug product development, manufacture, analytical testing, packaging/labeling and distribution to ensure timely delivery of drug supplies meeting all quality standards
Proficient with QbD concepts and Design of Experiments approaches to support formulation and process optimization. Familiar with statistical tools for data analysis
Thorough understanding of cGMP principals and practices as well as global regulatory requirements across different product lifecycle. Ensure cGMP compliance and regulatory adherence within the company and contract organizations.
Highly skilled and experienced in technical report and protocol writing. Author and review regulatory submission documents for CTA/IND/NDA filing as well as Pediatric Investigation Plan (PIP)
Strong technical expertise in solid oral dosage form development for poorly soluble compounds to improve bioavailability, drug product process development, scale-up, tech transfer and validation with sound understanding of major processing equipment and unit operations
Proficient with QbD concepts and Design of Experiments approaches to support formulation and process optimization, and validation for both spray dried dispersion (SDD) and finished product
Extensive experiences in collaborating with external CROs/CMOs for drug product development, manufacture, analytical testing, packaging/labeling and distribution to ensure timely delivery of drug supplies meeting all quality standards
Thorough understanding of cGMP principles and practices as well as global regulatory requirements across different product lifecycle. Proficient in regulatory document writing for CTA/IND/NDA
Self-motivated, comfortable in fast-paced small company environment. Highly organized and efficient with strong competencies in influencing and negotiation; Able to handle multiple projects simultaneously with a high degree of accuracy
SKILLS
Solid oral dosage form development
Process optimization, scale-up & validation
Poorly soluble compound enabling
Bioavailability improvement
Solid state characterization
Clinical Supply Chain Management
IND/CTA and NDA Document Preparation
Project management
Cross-functional Team Leadership
CMO/CRO Management
Contract Negotiation and Proposal Writing
Budget Forecasting and Resource Allocation
Team Building & Talent Recruitment
SOP and Procedure Development
Overview
20
20
years of professional experience
Work History
Vice President
InventisBio Co. Ltd
02.2021 - Current
Lead a group of 16 scientists, responsible for drug product development & manufacture, analytical development for drug substance and drug product as well as supply chain management to support on-going clinical trials through commercialization for all development compounds
Design the experiments for formulation/process development & optimization, process scale-up and validation to enable IND and NDA work packages
Develop drug product development strategies and timeline to support all phases of clinical studies and commercialization
Integrate with API development timeline and campaign planning
Coordinate with Discovery group for compound profiling and drug enabling to support development candidate nomination
Define packaging development plan and package design studies to support the container/closure and desiccant selection for commercial package
Streamline the process for clinical supply forecasting, labeling/distribution and combo drug sourcing & management for oncology projects to maximize supply efficiency and minimize the wastes
Manage department resources (headcount and capital equipment) and budget
Continue building and expanding the group with talented new hires to support the development activities and meet the project needs
Identify and leverage the external experts to support drug product process development and scale up
Identify the needs of capital equipment acquisition for manufacturing and analytical testing to increase the in-house capabilities for solid oral dosage form manufacture and testing.
As the head of CMC, responsible for drug product development & manufacture, analytical development for drug substance and drug product as well as supply chain management for all small molecule compounds to support the on-going clinical trials through commercialization
Worked closely with senior management to define the drug product development strategies and timeline, manage CMC budget and resources, and ensure all CMC activities to be completed on time in support of the aggressive clinical timelines
Identified and managed external CMOs for drug product development, clinical supply manufacture and release, packaging and labeling
Responsible for proposal writing, contract negotiation and budget planning
Developed strategies and designed experiments for formulation and process development & optimization
Oversee drug product development, manufacture and analytical testing at CMOs to ensure seamless executions of work packages
Provide technical review and approval for batch records, DP development and analytical method validation protocols, manufacturing deviations and OOS investigations as well as technical reports
Coordinated with Clinical Operations to project clinical demand requirements and ensure alignment with CMC plans and timelines for clinical supply manufacture
Supervised CROs for drug substance solid form screening/selection, characterization, preformulation and non-clinical formulation development to support chronic GLP Tox studies
Authored and reviewed IND/CTA documents to enable clinical studies in US, EU and APAC countries
Principal Scientist/Director
Pfizer/Medivation
06.2016 - 12.2017
Led drug product development for a challenging Phase III oncology project to support its NDA and commercial readiness
Responsible for API solid form characterization, clinical formulation/process and commercial product/process development to support clinical trial supply and registration batch manufacture
Defined strategies and design experiments for process development and optimization to improve process robustness and prepare for process validation
Oversee the batch production and analytical testing activities at CMO for drug product formulation/process development and clinical supply manufacture; Provide technical guidance and troubleshooting
Authored drug product development sections in support of NDA filing as well as IMPD documents
Led CMC subteam to consolidate DS and DP development plans, identify mitigation strategies to overcome the development challenges, and ensure all CMC work packages complete on-time to meet clinical timeline and project milestones
Responsible for formulation/process development and supply manufacture for NCE compounds to support non-clinical and Phase I/Phase II clinical studies, and project transfer to Late-Stage Development Center for process scale-up
Developed dosage form development strategies for different patient groups (adult, adolescents and children)
Identified and resolved all formulation & process related issues during development and manufacture
Overcome development hurdles of poorly soluble compounds and developed dosage forms using various solubilization approaches (combining API micronization & solubilizing agents, amorphous solid dispersion and nano-particles) to improve oral bioavailability
Designed and conducted DOE studies to optimize formulation and process; defined CMAs, CPPs, and their relationship to the product critical quality attributes
Experienced in various pharmaceutical processing technologies for solid oral dosage forms, such as spray drying, high shear granulation, fluid-bed granulation/drying, roller compaction, tableting, encapsulation, film-coating and wet extrusion
Coordianted with Medical and Marketing to define final product identifications (size/shape, color and imprinting) and developed dosage forms for improving patient compliance and marketing potential
Contributed to IND/CTA and NDA document preparation for drug product development and manufacturing process in support of all clinical trials and NDA submission.